Bilateral superficial cervical plexus block for Trans-oral endoscopic thyroidectomy. A randomized controlled study.

Bilateral superficial cervical plexus block for Trans-oral endoscopic thyroidectomy. A randomized controlled study. - Bilateral superficial cervical plexus block for Trans-oral endoscopic thyroidectomy.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035497

Enrollment

Registered

2019-01-19

Start date

2018-09-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recuriting

Interventions

First group will receive general anesthesia. (Group G) second group will receive bilateral superficial cervical plexus block with ropivacaine 0.5 % after general anesthesia (Group GB).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled for thyroid surgeries who are ASA (physical status) I or II or III with Gland width on diagnostic imaging less than ten ml, Outline of more than forty five cm ,Papillary microcarcinoma without local or distant.

Exclusion criteria

Exclusion criteria: Patients unfit for general anesthesia, Previous neck surgery or recurrent goiter,A gland more than 45 mL or distant metastases,Tracheal/esophageal infiltration, hyperthyroidism, mediastinal goiter,poorly- or un-differentiated cancer,

Design outcomes

Primary

Measure	Time frame
. The aim is to assess analgesic efficacy of cervical plexus block after general anesthesia for transoral thyroidectomy. The primary concern of this study is pain score.	—

Secondary

Measure	Time frame
The secondary goals are hospital stay, total analgesic consumption, and side effects.	—

Countries

Africa

Contacts

Public ContactAlaaeldin ELDEEB

Dr. anesthesia department

alaaeldeep9@hotmail.com+2050226261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026